febuxostat Oral Tablet [Uloric]

 
National Institutes of Health

Related topics

Related topics

2 relations
Oral Tablet

Narrower (1)

febuxostat 80 MG Oral Tablet [Uloric]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Febuxostat: A Review of Its Use in the Treatment of Hyperuricaemia in Patients with Gout
Febuxostat (Adenuric®, Uloric®, Feburic®) is an orally-active, potent, non-purine, selective xanthine oxidase inhibitor. In the… Expand
  • table 1
  • table 2
  • table 3
  • figure 2
  • table 4
Is this relevant?
2014
2014
Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: implications for identifying molybdopterin nitrite reductases.
Sources of nitric oxide alternative to nitric oxide synthases are gaining significant traction as crucial mediators of vessel… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2009
2009
HIGHLIGHTS OF PRESCRIBING INFORMATION These HIGHLIGHTS do not include all the information needed to use ULORIC safely and effectively. See full prescribing information for ULORIC
  • ULORIC febuxostat
  • 2009
------------------------DOSAGE AND ADMINISTRATION---------------------• ULORIC is recommended at 40 mg or 80 mg once daily. The… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?